WuXi, CANbridge establish first known partnership in China to tackle rare diseases: CEO 25-Oct-2018 By Melissa Fassbender WuXi Biologics and CANbridge Pharmaceutical have entered into a long-term partnership to develop and commercialize a portfolio of biotherapeutics for rare diseases.